Theratechnologies inc.

Theratechnologies inc.

September 28, 2007 08:15 ET

Theratechnologies to Present at BioContact Quebec

MONTREAL, QUEBEC--(Marketwire - Sept. 28, 2007) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer of the Company, will be presenting an overview of Theratechnologies at BioContact Quebec, which will take place at the Chateau Frontenac, in Quebec City. Mr. Rosconi will be speaking at 11:30 a.m., on Thursday, October 4. BioContact Quebec is a biopharmaceutical partnership symposium attended by over 1,200 participants.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, which has recently competed patient recruitment for its confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development.

Contact Information